血清和卵泡液代谢组与卵巢刺激标志物的关联
一项2009至2015年的前瞻性队列研究纳入125例行新鲜IVF周期的女性,采用非靶向代谢组学分析血清和卵泡液,发现血清中主要为脂肪酸和氨基酸通路、卵泡液中主要为脂质、维生素和激素通路与峰值雌二醇水平及成熟卵母细胞数相关。
要点
- 血清代谢组中脂肪酸和氨基酸通路与雌二醇水平及成熟卵母细胞数相关。
- 卵泡液代谢组中脂质、维生素和激素通路与峰值雌二醇及成熟卵母细胞数相关。
- 卵泡液中维生素D3通路与两项卵巢刺激结局的关联最强。
核心结论
- 血清和卵泡液中的代谢通路与卵巢刺激结局相关,可能为改善卵巢刺激结局提供新见解。
研究设计与样本
- 前瞻性队列研究,纳入2009至2015年在美国东北部一家生育诊所接受新鲜IVF周期的125名女性,采集血清和卵泡液样本。
- 采用液相色谱-高分辨质谱在C18和HILIC两种色谱柱上进行非靶向代谢组学分析。
- 使用调整的广义线性回归模型识别显著代谢特征,调整年龄、BMI、初始不孕诊断和卵巢刺激方案。
- 采用mummichog进行通路分析,并使用level-1证据进行代谢物注释。
主要发现
- 血清代谢组中,C18和HILIC柱分别有480和850个特征与峰值雌二醇水平相关。
- 血清代谢组中,C18和HILIC柱分别有437和538个特征与成熟卵母细胞数相关。
- 卵泡液代谢组中,C18和HILIC柱分别有752和929个特征与峰值雌二醇水平相关。
- 卵泡液代谢组中,C18和HILIC柱分别有993和986个特征与成熟卵母细胞数相关。
- 与峰值雌二醇相关的最常见通路包括脂肪酸(血清和卵泡液)、激素(卵泡液)和脂质通路(卵泡液);与成熟卵母细胞数相关的最常见通路包括氨基酸(血清)、脂肪酸(血清和卵泡液)、激素(卵泡液)和维生素通路(卵泡液)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 样本多数为白人和高教育程度人群,可能无法推广至更广泛人群。
- 可能存在残余混杂。
- 卵泡液冲洗介质可能稀释结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What metabolic pathways and metabolites in the serum and follicular fluid are associated with peak estradiol levels and the number of mature oocytes? SUMMARY ANSWER: In the serum metabolome, mostly fatty acid and amino acid pathways were associated with estradiol levels and mature oocytes while in the follicular fluid metabolome, mostly lipid, vitamin, and hormone pathways were associated with peak estradiol levels and mature oocytes. WHAT IS KNOWN ALREADY: Metabolomics has identified several metabolic pathways and metabolites associated with infertility but limited data are available for ovarian stimulation outcomes. STUDY DESIGN, SIZE, DURATION: A prospective cohort study of women undergoing IVF from 2009 to 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 125 women undergoing a fresh IVF cycle at a fertility clinic in the Northeast United States who provided a serum and follicular fluid sample. Untargeted metabolomics profiling was conducted using liquid chromatography with high-resolution mass spectrometry in two chromatography columns (C18 and hydrophilic interaction chromatography (HILIC)). The main ovarian stimulation outcomes were peak serum estradiol levels and number of mature oocytes. We utilized adjusted generalized linear regression models to identify significant metabolic features. Models were adjusted for age,BMI, initial infertility diagnosis, and ovarian stimulation protocol. We then conducted pathway analysis using mummichog and metabolite annotation using level-1 evidence. MAIN RESULTS AND ROLE OF CHANCE: In the serum metabolome, 480 and 850 features were associated with peak estradiol levels in the C18 and HILIC columns, respectively. Additionally, 437 and 538 features were associated with mature oocytes in the C18 and HILIC columns, respectively. In the follicular fluid metabolome, 752 and 929 features were associated with peak estradiol levels in the C18 and HILIC columns, respectively, Additionally, 993 and 986 features were associated with mature oocytes in the C18 and HILIC columns, respectively. The most common pathways associated with peak estradiol included fatty acids (serum and follicular fluid), hormone (follicular fluid), and lipid pathways (follicular fluid). The most common pathways associated with the number of mature oocytes retrieved included amino acids (serum), fatty acids (serum and follicular fluid), hormone (follicular fluid), and vitamin pathways(follicular fluid). The vitamin D3 pathway had the strongest association with both ovarian stimulation outcomes in the follicularfluid. Four and nine metabolites were identified using level-1 evidence (validated identification) in the serum and follicular fluid metabolomes, respectively. LIMITATIONS, REASONS FOR CAUTION: Our sample was majority White and highly educated and may not be generalizable to thewider population. Additionally, residual confounding is possible and the flushing medium used in the follicular fluid could have diluted our results. WIDER IMPLICATIONS OF THE FINDINGS: The pathways and metabolites identified by our study provide novel insights into the biologicalmechanisms in the serum and follicular fluid that may underlie follicular and oocyte development, which could potentially be used to improve ovarian stimulation outcomes. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the following grants from the National Institute of Environmental Health Sciences (P30-ES019776, R01-ES009718, R01-ES022955, P30-ES000002, R00-ES026648, and T32-ES012870), and National Institute of Diabetes and Digestive and Kidney Diseases (P30DK046200). The authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: N/A.
引用
- Hood RB, Liang D, Tan Y, et al. Serum and follicular fluid metabolome and markers of ovarian stimulation. Hum Reprod. 2023. PMID: 37740688. doi:10.1093/humrep/dead189
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。